Cyclogyl

Active Ingredient(s): Cyclopentolate
FDA Approved: * July 31, 1974
Pharm Company: * ALCON
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Cyclogyl Overview

Cyclopentolate is a muscarinic antagonist[1]. It is commonly used as an eye drop during pediatric eye examinations to dilate the eye (mydriatic) and prevent the eye from focusing/accommodating (cycloplegic). Cyclopentolate or atropine can also be administered to reverse muscarinic and central nervous system effects of indirect cholinomimetic (anti-AChase) administration. After instillation of cyclopentolate, pupil dilation (mydriasis) typically lasts up to 24 hours, while pa...

Read more Cyclogyl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cyclopentolate

Recent Cyclogyl Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cyclopentolate
  • Solution: 0.5%, 1%, 2%
  • Solution/drops: 0.5%, 0.50%, 1%, 2%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cyclogyl: (3 results)

Sorted by National Drug Code
  • 0065-0395 Cyclogyl 5 mg/ml Ophthalmic Solution by Alcon Laboratories, Inc.
  • 0065-0396 Cyclogyl 10 mg/ml Ophthalmic Solution by Alcon Laboratories, Inc.
  • 0065-0397 Cyclogyl 20 mg/ml Ophthalmic Solution by Alcon Laboratories, Inc.

Other drugs which contain Cyclopentolate or a similar ingredient: (5 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 22 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA